Description

Hippocampus.- Redox dysregulation in schizophrenia: Genetic susceptibility and pathophysiological mechanisms.- An overview and current perspective on family studies of schizophrenia.- Synaptic vesicle associated proteins and schizophrenia.- Cortical dopamine in schizophrenia.- G72/g30 in neuropsychiatric disorders.- Cholinergic mechanisms in schizophrenia.- The neurobiology of negative symptoms and the deficit syndrome.- Alterations of neurotransmitter receptors in schizophrenia: Evidence from postmortem studies.- Auditory cortex anatomy and asymmetry in schizophrenia.- Event related potentials (ERPS) in the study of schizophrenia: How pre-clinical ERP studies have contributed to our understanding of schizophrenia.- Neuregulin 1 and schizophrenia.- The role of prefrontal abnormalities in schizophrenia.- Early-stage visual processing deficits in schizophrenia and implications for higher level function.- Magnetic resonance spectroscopy.- Dysbindin-1 and its protein family.- Glutamate and schizophrenia: Phencyclidine, n-methyl-d-aspartate (NMDA) receptors: Etiology and treatment.